Fludarabine may induce durable remission in patients with leptomeningeal involvement of chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 46, Issue 11, 2005, Pages 1593-1598

  Knop, Stefan ^a   Herrlinger, Ulrich ^a   Ernemann, Ulrike ^a   Kanz, Lothar ^a   Hebart, Holger ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CLL; CSF; Fludarabine; Leptomeningeal involvement; Lymphomatous meningitis

Indexed keywords

CANCER VACCINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUDARABINE; PREDNISONE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BRAIN RADIATION; CANCER REGRESSION; CANCER SURVIVAL; CEREBROSPINAL FLUID ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CYTOLOGY; FEMALE; HUMAN; IMMUNOPHENOTYPING; MALE; MENINGEAL METASTASIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CEREBROSPINAL FLUID; DRUG EVALUATION; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; LEUKEMIA, B-CELL, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; VIDARABINE;

EID: 28244440911     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500178472     Document Type: Article

References (16)

1. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995;333:1052-1057.
2. Ferrajoli A, O'Brien SM. Treatment of chronic lymphocytic leukemia. Semin Oncol 2004;31(2 Suppl 4):60-65.
3. Brick WG, Majmundar M, Hendricks LK, Kallab AM, Burgess RE, Jillella AP. Leukemic leptomeningeal involvement in stage 0 and stage 1 chronic lymphocytic leukemia. Leuk Lymphoma 2002;43:199-201.
4. Barcos M, Lane W, Gomez GA, Han T, Freeman A, Preisler H, Henderson E. An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer 1987;60:827-837.
5. Oscier D, Fegan C, Hillmen P, Illidge T, Johnson S, Maguire P, Matutes E, Milligan D. Guidelines Working Group of the UK CLL Forum. British Committee for Standards in Haematology. Guidelines on the diagnosis and management of chronic lymphocytic leukaemia. Br J Haematol 2004;125:294-317.
6. Marmont AM. Leukemic meningitis in B-cell chronic lymphocytic leukemia: resolution following intrathecal methotrexate. Blood 2000;96:776-777.
7. Herrlinger U, Forschler H, Kuker W, Meyermann R, Bamberg M, Dichgans J, Weller M. Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 2004;223:167-178.
8. Remission of leukaemic meningitis after fludarabine. Lancet. 1995;346:972.
9. Miller K, Budke H, Orazi A. Leukemic meningitis complicating early stage chronic lymphocytic leukemia. Arch Pathol Lab Med 1997;5:524-527.
10. Hoffman MA, Valderrama E, Fuchs A, Friedman M, Rai K. Leukemic meningitis in B-cell prolymphocytic leukemia. A clinical, pathologic, and ultrastructural case study and a review of the literature. Cancer 1995;75:1100-1103.
11. Van den Bent MJ, Lamers CH, van't Veer MB, Sillevis Smitt PA, Bolhuis RL, Gratama JW. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies. Ann Hematol 2002;81:187-191.
12. Nowakowski GS, Call TG, Morice WG, Kurtin PJ, Cook RJ, Zent CS. Clinical significance of monoclonal B cells in cerebrospinal fluid. Cytometry B Clin Cytom 2005;63: 23-27.
13. Elliott MA, Letendre L, Chin-Yang L, Hoyer J and Hammack JE. Chronic lymphocytic leukaemia with symptomatic diffuse central nervous system infiltration responding to therapy with systemic fludarabine. Br J Haematol 1999;104: 689-694.
14. Cheson BD, Vena DA, Foss FM, Sorensen JM. Neurotoxicity of purine analogs: a review. J Clin Oncol 1994;12: 2216-2228.
15. Saumoy M, Castells G, Escoda L, Mares R, Richart C, Ugarriza A. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. Leuk Lymphoma 2002;43:433-436.
16. Lindemalm S, Liliemark J, Larsson BS, Albertioni F. Distribution of 2-chloro-2′-deoxyadenosine, 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography study. Med Oncol 1999;16:239-244.